Divi’s Laboratories Share Price Surges Over 5% After Q2 FY27 Earnings Results; PAT Rises 64% to ₹1,127 Crore

Divi’s Laboratories reported a sharp jump in earnings for the September quarter, with consolidated profit after tax reaching ₹1,127 crore in Q2 FY27.
The figure was up from ₹689 crore in the same quarter last year, while consolidated total income rose to ₹3,770 crore from ₹2,860 crore.
Stronger Profit Performance in Q2
Profit before tax for the quarter stood at ₹1,505 crore, compared with ₹912 crore a year earlier.
The company's PAT rose by around 64% year-on-year, while total income recorded growth of nearly 32%.
First-Half Earnings Also Move Higher
The growth continued during the first six months of the financial year. Consolidated total income for H1 FY27 came in at ₹6,907 crore, against ₹5,389 crore in the corresponding period last year.
Profit before tax increased to ₹2,685 crore from ₹1,645 crore. Meanwhile, half-year PAT rose to ₹2,029 crore from ₹1,234 crore.
Lower Forex Gains During the Period
Forex gains were lower compared with the previous year. The company recorded a forex gain of ₹24 crore in Q2 FY27, against ₹63 crore in Q2 FY26.
For the first half, forex gain stood at ₹17 crore, compared with ₹102 crore in the corresponding period last year.
Read More: Marico Share Price in Focus; To Acquire 51% Stake in Bonorizon for ₹35 Crore!
Divi’s Laboratories Share Price Performance
As of 09 November 2026, at 11:26 AM, Divi’s Laboratories Ltd share price is trading at ₹11,485 per share, reflecting a surge of 3.50% from the previous trading session.
Conclusion
Divi’s Laboratories reported higher income and a significant rise in profitability during Q2 FY27. The September quarter also helped push its consolidated PAT for the first half above ₹2,000 crore.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Nov 9, 2026, 1:02 PM IST

Team Angel One
- Larsen & Toubro Share Price in Focus; Secures Noida Metro Aqua Line Extension Project Order
- Morepen Laboratories Share Price Gains Over 4%; Enters US Prescription Generics Market with Desloratadine Launch
- Adani Enterprises Share Price in Focus as AdaniConneX Completes Acquisition of 100% Stake in Vizag Mega Data Center Park Limited
- Marico Share Price in Focus; To Acquire 51% Stake in Bonorizon for ₹35 Crore
- Valor Estate Share Price Declines Over 5% as Q2FY27 Net Profit Falls 15.9%




